Combined intra‑articular and peri‑articular PRP injections for chronic knee osteoarthritis
Official title: The Effects of Platelet-rich Plasma (PRP) Injections Administered Into Intra-articular and Periarticular Regions Under Ultrasound Guidance in Chronic Knee Osteoarthritis on Pain, Function, Activities of Daily Living, Medial Collateral Ligament (MCL) and Distal Femoral Cartilage Thickness
Run by Ankara City Hospital Bilkent · NCT07339137 · Data updated 2026-11-12
This will test whether adding ultrasound-guided peri‑articular PRP injections to intra‑articular PRP helps adults 40–65 with moderate medial knee osteoarthritis have less pain and better function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 65 Years |
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | Ankara City Hospital Bilkent Academic / other |
| Locations | 1 site (Ankara, Çankaya) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | February 1, 2026 |
| Study ends | April 30, 2026 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT07339137 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40–65 with medial knee pain from Kellgren‑Lawrence grade 2–3 osteoarthritis, VAS ≥4, who have failed at least three months of conservative treatment and can give informed consent.
✕Probably not a fit
People with prior knee trauma or surgery, recent intra‑articular steroid or hyaluronic acid injections, inflammatory arthritis, active infection, bleeding disorders, uncontrolled major comorbidities, or current cancer are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with medial knee osteoarthritis (Kellgren‑Lawrence grade 2–3) receive ultrasound-guided platelet-rich plasma (PRP) injections either into the joint alone or combined with peri‑articular injections targeting structures such as the MCL and pes anserinus. The trial compares pain, physical function, activities of daily living, and structural ultrasound measures including medial collateral ligament thickness and distal femoral cartilage thickness between the two approaches. Eligibility emphasizes persistent medial knee pain (VAS ≥4) after at least three months of conservative care and excludes recent knee injections, prior knee surgery, inflammatory arthropathies, active infection, or significant bleeding disorders. Outcomes will determine whether targeting both intra‑articular and peri‑articular tissues yields greater symptomatic and structural benefit than intra‑articular PRP alone.
Why it matters
Potential benefit: If successful, the combined approach could reduce pain and improve daily function more than intra‑articular PRP alone and may better address peri‑articular contributors to knee symptoms.
How similar studies have gone: Intra‑articular PRP has shown pain and function benefits in prior studies, but adding peri‑articular PRP is a less-studied, more novel approach with limited published evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Age between 40 and 65 years. * Patients with significant medial knee pain who have not responded to conservative treatment for at least 3 months. * Patients diagnosed with knee osteoarthritis according to the American College of Rheumatology (ACR) criteria and with Kellgren-Lawrence grade 2 or 3 radiographic osteoarthritis. * Intact cognitive function. * Willingness to participate in the study and provide signed informed consent. * Visual Analog Scale (VAS) score of 4 or higher. Exclusion Criteria * History of previous knee trauma or surgery. * Physical therapy, intra-articular steroid, or hyaluronic acid injections in the knee within the last 3 months. * Active oncological diseases. * Local infection, sepsis, wounds, or scars in the injection area. * Systemic infections, hepatitis, or immunosuppression. * Bleeding diathesis or irregular International Normalized Ratio (INR) due to oral warfarin use. * Inflammatory arthropathies. * Uncontrolled hypertension, uncontrolled diabetes mellitus, decompensated heart failure, coronary artery disease, or asthma. * Suspected or confirmed pregnancy. * Use of corticosteroids or opioids. * Anemia. * Body mass index (BMI) greater than 35. * Allergy to citrate. * Use of nonsteroidal anti-inflammatory drugs (NSAIDs) within the last week that may affect platelet function analyzer-100 (PFA-100) activity. * Physical examination findings suggestive of patellar retinaculum, meniscus, or cruciate ligament injury. * General health impairment or lack of cooperation. * Refusal to participate in the study.
Where it's running
-
Ankara Bilkent City Hospital, Physical Therapy and Rehabilitation Hospital
Ankara, Çankaya, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Rıdvan E ÇELİK
- Email: ridvancelik94@gmail.com
- Phone: +905078414386
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Core muscle function and balance in people with leg amputations
This study tests how leg amputation affects core muscles and balance by comparing muscle thickness on the amputated side, the intact side, and healthy people using ultrasound.
-
Tail Fat Application for Knee Osteoarthritis Pain and Stiffness
This study tests whether applying sheep tail fat to the knee helps reduce pain and stiffness and improves daily activity in adults with gonarthrosis.
-
Knee Osteoarthritis: See If Your Treatment Beliefs Help Your Physical Therapy
This study will look to see if what patients expect from physical therapy influences the benefits they get for knee osteoarthritis.
-
Benchmark and performance test for AI reading breast ultrasound images
This project will test whether multimodal AI models can read breast ultrasound images to help classify normal, benign, and malignant findings for people who have had breast ultrasound.
-
Platelet-Rich Plasma from Two Different Systems in Knee Osteoarthritis
This study compares PRP made by two FDA-approved machines to see if the platelets differ and whether injections help knee symptoms.
-
Oral vs IV Dexamethasone in Knee Replacement Recovery
This real-world study compares how giving dexamethasone by mouth or by IV around knee replacement affects early pain, movement, and recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.